Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
M Aguilar-Bretones, RAM Fouchier… - The Journal of clinical …, 2023 - jci.org
Infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
vaccinations targeting the spike protein (S) offer protective immunity against coronavirus …
vaccinations targeting the spike protein (S) offer protective immunity against coronavirus …
Seasonal coronavirus–specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19
M Aguilar-Bretones, BM Westerhuis, MP Raadsen… - The Journal of clinical …, 2021 - jci.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus
disease 2019 (COVID-19). Little is known about the interplay between preexisting immunity …
disease 2019 (COVID-19). Little is known about the interplay between preexisting immunity …
SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity
M Aguilar-Bretones, Y den Hartog, LLA van Dijk… - npj Vaccines, 2024 - nature.com
Healthy individuals with hybrid immunity, due to a SARS-CoV-2 infection prior to first
vaccination, have stronger immune responses compared to those who were exclusively …
vaccination, have stronger immune responses compared to those who were exclusively …
Severe COVID-19 patients display a back boost of seasonal coronavirus-specific antibodies
BM Westerhuis, M Aguilar-Bretones, MP Raadsen… - MedRxiv, 2020 - medrxiv.org
Severe acquired respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of
coronavirus disease (COVID-19). In severe COVID-19 cases, higher antibody titers against …
coronavirus disease (COVID-19). In severe COVID-19 cases, higher antibody titers against …
[HTML][HTML] Novel approaches for the rapid development of rationally designed arbovirus vaccines
JWM van Bree, I Visser, JM Duyvestyn… - One Health, 2023 - Elsevier
Vector-borne diseases, including those transmitted by mosquitoes, account for more than
17% of infectious diseases worldwide. This number is expected to rise with an increased …
17% of infectious diseases worldwide. This number is expected to rise with an increased …
Human B cells and dendritic cells are susceptible and permissive to enterovirus D68 infection
BM Laksono, S Sooksawasdi Na Ayudhya… - Msphere, 2024 - journals.asm.org
ABSTRACT Enterovirus D68 (EV-D68) is predominantly associated with mild respiratory
infections, but can also cause severe respiratory disease and extra-respiratory …
infections, but can also cause severe respiratory disease and extra-respiratory …
[PDF][PDF] Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients
M Aguilar-Bretones, MPG Koopmans… - Journal of Clinical … - researchgate.net
ABSTRACT 1 Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause
of coronavirus 2 disease 2019 (COVID-19). Little is known about the interplay between pre …
of coronavirus 2 disease 2019 (COVID-19). Little is known about the interplay between pre …
The potential role of human immune cells in the systemic dissemination of enterovirus-D68
BM Laksono, SS Na Ayudhya, M Aguilar-Bretones… - bioRxiv, 2022 - biorxiv.org
Abstract Enterovirus-D68 (EV-D68) often causes mild respiratory infections, but can also
cause severe respiratory infections and extra-respiratory complications, including acute …
cause severe respiratory infections and extra-respiratory complications, including acute …
[CITATION][C] GP van Nierop Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity., 2023, 133, p. e162192
M Aguilar-Bretones, RA Fouchier, MP Koopmans - DOI: https://doi. org/10.1172/JCI162192
[CITATION][C] Severe COVID-19 patients display a back boost of seasonal coronavirus-specific antibodies. medRxiv 2020; published online Oct 12
BM Westerhuis, M Aguilar-Bretones, MP Raadsen